Funding, M&A, exec moves and hiring — matched to your market, with the people to call.See plans →
Innocens raises €1.5M in a Pre-Seed round led by BAN Flanders, BeAngels, and others to support clinical validation and commercial expansion.
PRIVATEAug 11, 2026•about 2 hours ago
Amount Raised
€1.5 Million
Round Type
Seed
Investors
QbicLrmNxtBe AngelsBan Flanders
Description
Innocens, a health tech startup from Antwerp, has successfully raised €1.5 million in a Pre-Seed funding round. This funding will be used for clinical validation studies and to accelerate the commercial rollout of its technology. The round saw participation from BAN Flanders, BeAngels, NXT, LRM, Qbic, and existing shareholders. Founded in 2021, Innocens aims to enhance monitoring of premature babies through AI-powered solutions.
Funding Insights
Based on industry dataVC-backed spending patterns
VC-backed companies spend 89% more on sales and 100% more on marketing than bootstrapped peers